In this interview Hussein Al-Qasim, Head of Serialisation and Tamper Evidence, Genericon Pharma, speaks to Andrea Charles from Pharma IQ about the specific issues surrounding serialisation strategy that will affect contract manufacturing organisations (CMOs) and shares his thoughts on the future serialisation in the MENA region.
Pharma IQ: With the global pharmaceutical contract manufacturing market on the rise, what are the specific issues around serialisation strategy that will affec...
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
AI for Pharma & Healthcare
23 - 25 September, 2025
Amsterdam
Register Now |
View Agenda |
Learn More